The pharmaceutical landscape in this country is increasingly characterized by a appearance toward market concentration, with a handful of prominent companies wielding significant power. These sector giants, often bolstered by long-standing distribution networks and considerable brand recognition, present a difficult picture for competition and acce

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces rising concerns about monopolies. A few dominant companies control a significant percentage of the market, potentially limiting competition and driving up prices for consumers. This issue raises questions about the long-term impact on patient access to aff